TCM
COGT icon

Tekla Capital Management’s Cogent Biosciences COGT Stock Holding History

Tekla Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-146,911
Closed -$1.32M – 173
2022
Q2 		$1.32M Buy
+146,911
New +$1M 0.05% 126
2021
Q3 		– Sell
-537,742
Closed -$4.36M – 180
2021
Q2 		$4.36M Hold
537,742
– – 0.14% 125
2021
Q1 		$4.72M Hold
537,742
– – 0.16% 120
2020
Q4 		$6.04M Buy
537,742
+261,948
+95% +$2.88M 0.21% 110
2020
Q3 		$2.58M Buy
+275,794
New +$2.88M 0.1% 140

Other funds holding COGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return